Cargando…
Preventive Trichuris suis ova (TSO) treatment protects immunocompetent rabbits from DSS colitis but may be detrimental under conditions of immunosuppression
Trichuris suis ova (TSO) have been tested for therapeutic application in inflammatory bowel diseases (IBD) yet understanding of the underlying mechanisms and safety in an immunocompromised host is limited due to lack of a suitable animal model. We used a recently established rabbit model of dextran...
Autores principales: | Leonardi, Irina, Gerstgrasser, Alexandra, Schmidt, Thomas S. B., Nicholls, Flora, Tewes, Bernhard, Greinwald, Roland, von Mering, Christian, Rogler, Gerhard, Frey-Wagner, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705695/ https://www.ncbi.nlm.nih.gov/pubmed/29184071 http://dx.doi.org/10.1038/s41598-017-16287-4 |
Ejemplares similares
-
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease
por: Schölmerich, Jürgen, et al.
Publicado: (2017) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018) -
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
por: Yordanova, Ivet A., et al.
Publicado: (2021) -
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
por: Rosche, Berit, et al.
Publicado: (2013)